CHILDRENS SPECIALIZED HOPSITAL
1. Target Overview & Investment Thesis
CHILDRENS SPECIALIZED HOPSITAL is a 68-bed suburban community hospital in UNION, NJ with $150.1M in net patient revenue and a -18.1% operating margin. The hospital serves a payer mix of 0.1% Medicare, 10.0% Medicaid, and 89.9% commercial.
Thesis: Turnaround. Our ML models identify $11.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -18.1% to -10.7% (+736bps).
| Net Revenue HCRIS | $150.1M |
| Current EBITDA COMPUTED | $-27.2M |
| Operating Margin COMPUTED | -18.1% |
| Occupancy HCRIS | 80.5% |
| Revenue / Bed COMPUTED | $2.2M |
| Net-to-Gross HCRIS | 55.2% |
| Distress Probability ML | 42.6% |
2. Market Context & Competitive Position
NJ has 95 Medicare-certified hospitals with a median operating margin of -3.9%. The target's margin of -18.1% places it below the state median. Among 32 size-comparable peers (34-136 beds), the median margin is -2.7%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (34-136), prioritizing same-state peers. 32 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| CHILDRENS SPECIALIZED HOPSITAL (Target) | NJ | 68 | $150.1M | -18.1% |
| DEBORAH HEART AND LUNG CENTER | NJ | 85 | $211.9M | -5.5% |
| ST LUKES WARREN HOSPITAL | NJ | 92 | $200.8M | 28.1% |
| BERGEN NEW BRIDGE MEDICAL CENT | NJ | 101 | $187.0M | -39.4% |
| ST. MARYS HOSPITAL - PASSAIC | NJ | 122 | $173.8M | 0.9% |
| HUDSON REGIONAL HOSPITAL | NJ | 102 | $152.7M | 2.4% |
| HACKENSACK UMC AT PASCACK VALL | NJ | 78 | $148.8M | 15.0% |
| BAYONNE MEDICAL CENTER | NJ | 131 | $141.4M | -25.9% |
| HOBOKEN UNIVERSITY MEDICAL CEN | NJ | 114 | $133.9M | -48.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $11.1M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $3.2M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $3.0M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $3.0M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.8M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $96K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-27.2M |
| + RCM Uplift | +$11.1M |
| Pro Forma EBITDA | $-16.1M |
| Current Margin | -18.1% |
| Pro Forma Margin | -10.7% |
| WC Released (1x) | $5.8M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-41.8M | $-68.7M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-41.8M | $-89.1M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-37.6M | $-66.2M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-37.6M | $-83.4M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-46.0M | $-110.4M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-46.0M | $-136.3M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 32 hospitals with 34-136 beds
- Same-state prioritization (n=33)
- Comp margins: P25=-28.9% / P50=-2.7% / P75=4.4%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.